Schedule 13D ownership disclosure

Lineage Cell Therapeutics Inc

Security class unavailable · CUSIP: 53566P109

Event date: 2024-02-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
22.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-24-000756
Form type
SC 13D/A
Filer
BROADWOOD PARTNERS, L.P.
CIK
CIK 1278386
Filed
Feb 08, 2024
Reporting period
Feb 06, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub